Who is sponsoring NCT03404310?

NCT03404310 is sponsored by Corewell Health West.

What condition does NCT03404310 study?

NCT03404310 studies Human Papilloma Virus.

What drugs are being tested in NCT03404310?

Interventions: Zinc Sulfate, Placebo (Gelatin Tablet).

What is the status of NCT03404310?

NCT03404310 is currently TERMINATED.

Last reviewed 2023-09-22 · How we verify

Zinc Sulfate for Human Papillomavirus (HPV)

NCT03404310 NA TERMINATED

The Human Papillomavirus (HPV) is well established as the primary causative agent in both warts and cervical cancer. Although cervical high risk HPV (hrHPV) infections have a high rate of spontaneous resolution this takes time and the infection can cause cervical cells to progress to precancerous and cancerous lesions. Zinc has been shown to play a central role in immunity. This study is to determine if oral zinc sulfate can improve clearance rates of high risk HPV versus placebo.

Details

Lead sponsor	Corewell Health West
Phase	NA
Status	TERMINATED
Enrolment	21
Start date	Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Jun 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Human Papilloma Virus

Interventions

Zinc Sulfate
Placebo (Gelatin Tablet)

Countries

United States